Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
BackgroundEpithelial ovarian cancer (EOC) is a cancer that affects the female reproductive system and is highly lethal. It poses significant challenges in terms of treatment and often has a poor prognosis. In recent years, with the advent of PARPi, the treatment of ovarian cancer has entered a new s...
Saved in:
| Main Authors: | Jingfang Wang, Wenrui Zhu, Xia Li, Yuanyuan Wu, Wenhui Ma, Yangzhou Wang, Weihong Zhao, Fang Wei, Wenhao Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1500251/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer
by: Chen Zhang, et al.
Published: (2023-12-01) -
Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope
by: Jan Brancewicz, et al.
Published: (2025-06-01) -
Unraveling the role of M2 TAMs in ovarian cancer dynamics: a systematic review
by: Yaping Wang, et al.
Published: (2025-06-01) -
How to Use Macrophages Against Cancer
by: Jacek Kuźnicki, et al.
Published: (2024-11-01) -
Construction of mitochondrial signature (MS) for the prognosis of ovarian cancer
by: Miao Ao, et al.
Published: (2025-07-01)